Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Shares Issued (2023 - 2025)

Immunocore Holdings' Shares Issued history spans 3 years, with the latest figure at -$8.1 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 1570.36% year-over-year to -$8.1 million; the TTM value through Sep 2025 reached $8.6 million, down 30.93%, while the annual FY2024 figure was $6.8 million, 80.2% down from the prior year.
  • Shares Issued for Q4 2025 was -$8.1 million at Immunocore Holdings, down from $1.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $17.7 million in Q2 2023 and bottomed at -$8.1 million in Q4 2025.
  • The 3-year median for Shares Issued is $2.6 million (2025), against an average of $3.7 million.
  • The largest YoY upside for Shares Issued was 1131.54% in 2025 against a maximum downside of 1570.36% in 2025.
  • A 3-year view of Shares Issued shows it stood at $6.3 million in 2023, then crashed by 91.21% to $550000.0 in 2024, then plummeted by 1570.36% to -$8.1 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Shares Issued are -$8.1 million (Q4 2025), $1.9 million (Q3 2025), and $3.7 million (Q2 2025).